rs606231207
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_004959.5(NR5A1):c.390del(p.Pro131ArgfsTer165) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Synonymous variant affecting the same amino acid position (i.e. P130P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
NR5A1
NM_004959.5 frameshift
NM_004959.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -5.91
Genes affected
NR5A1 (HGNC:7983): (nuclear receptor subfamily 5 group A member 1) The protein encoded by this gene is a transcriptional activator involved in sex determination. The encoded protein binds DNA as a monomer. Defects in this gene are a cause of XY sex reversal with or without adrenal failure as well as adrenocortical insufficiency without ovarian defect. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-124500569-GC-G is Pathogenic according to our data. Variant chr9-124500569-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 12807.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr9-124500569-GC-G is described in Lovd as [Likely_pathogenic]. Variant chr9-124500569-GC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NR5A1 | NM_004959.5 | c.390del | p.Pro131ArgfsTer165 | frameshift_variant | 4/7 | ENST00000373588.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NR5A1 | ENST00000373588.9 | c.390del | p.Pro131ArgfsTer165 | frameshift_variant | 4/7 | 1 | NM_004959.5 | P1 | |
NR5A1 | ENST00000620110.4 | c.390del | p.Pro131ArgfsTer163 | frameshift_variant | 4/6 | 5 | |||
NR5A1 | ENST00000455734.1 | c.390del | p.Pro131ArgfsTer? | frameshift_variant | 4/4 | 3 | |||
NR5A1 | ENST00000373587.3 | c.40-298del | intron_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Premature ovarian failure 7 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 19, 2009 | - - |
46,XY sex reversal 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 19, 2009 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at